Clinical Trials Browser

Unknown × trametinib × Other solid neoplasm × Clear all

NCT04965220 2023-08-09

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor